comparemela.com

Latest Breaking News On - Tim illidge - Page 1 : comparemela.com

EQS-News: Apogenix AG: Apogenix' new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model

EQS-News: Apogenix AG / Key word(s): Scientific publication Apogenix AG: Apogenix’ new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model 01.06.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. Apogenix’ new CD40 agonist.

United-kingdom
Germany
Heidelberg
Baden-wüberg
Manchester
Tim-illidge
Brigitte-keller
Judith-teumer
Katja-arnold
Thomas-hoeger
Mc-services
European-medicines-agency

vimarsana © 2020. All Rights Reserved.